Aixtron SE: Opto Visibility Improves, but Valuation Leaves Limited Upside

Core Conclusion

Aixtron’s optoelectronics opportunity has become tangible with multi-tool orders across geographies and management’s 60-120 G10-AsP tools-per-year estimate. The market has already priced in a sustained opto build near the upper end of that range, leaving the stock trading at 37.8x FY27e EPS—above Morgan Stanley’s €45 price target. While the AI-driven optical demand is real, execution risks on yield, architecture shifts, and wafer size transitions, plus an already-modeled GaN recovery, limit near-term upside. We maintain an Equal-weight rating.

What the Market Is Underappreciating

The market appears to extrapolate the recent order momentum into a multi-year linear build, implicitly discounting three risks: (1) the actual tool count depends heavily on laser yield, architecture (EML vs. CW), and wafer size—factors beyond Aixtron’s control; (2) the initial tool build could be followed by digestion, reducing 2028 follow-on demand; (3) GaN power recovery is already embedded in estimates (MS models a doubling of GaN revenue from ~€30m in FY25e to ~€60m in FY28e), leaving little room for upside surprise if utilization stays uneven.

Evidence Chain

Theme 1: Opto demand has broadened rapidly, but the inflection may be concentrated. Management confirmed that in the last eight weeks, Aixtron received multi-tool orders from customers in the US (including US players producing in Europe), Japan, Taiwan, China, and Europe. 1Q26 order intake of €171m was ~70% opto, making Aixtron effectively a data-center AI play. Investment implication: the geographic breadth is a positive, but the fact that orders surged only after NVIDIA’s early-March supply-chain investments suggests the timing was catalyzed by a single player. Follow-on orders beyond 2027 depend on that customer’s own capacity deployment.

Theme 2: Management’s tool estimate is wide and uncertain; sell-side forecasts are below the midpoint. Initially management cited 80-100 G10-AsP tools per year, but on the call the range widened to 60-120, reflecting dependence on laser architecture, link speeds, wafer size (transition to 6-inch), and yield rates. Morgan Stanley models 55/80/70 tools in FY26e/FY27e/FY28e, conservatively below the midpoint of the revised range. Investment implication: the stock at current levels discounts the upper half of management’s band. If actual tool demand lands near 60-70 per year—consistent with historical MOCVD cycles—earnings would fall short.

Theme 3: The stock already trades above the price target, offering limited near-term upside. As of April 30, 2026, the share price was €46.98, versus the Morgan Stanley price target of €45 (37x FY27e EPS). The target multiple was raised from 35x to 37x to reflect better opto visibility, but the market has already exceeded it. EPS forecasts saw only modest changes (+2% for FY27e/FY28e on higher gross margin assumptions). At 37.8x FY27e EPS, the premium to the 5-year average is fully reflecting the improved setup. Investment implication: near-term total return is likely negative to flat unless FY27 forecasts are revised up by at least 10-15%.

Key Risks

• Order digestion: After the initial tool build for laser capacity, follow-on orders may slow in 2028, reducing revenue visibility.
• SiC demand recovery: A rebound in SiC could create supply constraints, accelerating strategic ordering but also increasing uncertainty around lead times and cost.
• GaN power ramp delays: GaN revenue doubling by FY28e assumes customer capex in power electronics materializes; uneven utilization could push the inflection out.
• Legacy market drag: Persistent underutilization in LED and legacy markets keeps gross margins below mid-cycle levels, limiting operating leverage.

Valuation or Trade Implications

At €46.98, Aixtron trades at 37.8x FY27e EPS (MS estimate). The bull case of €65 (40x FY27e EPS) requires a sustained opto build above 100 tools/year plus an accelerated GaN recovery, while the bear case of €22 (25x) assumes a sharper SiC contraction and weaker opto/GaN. The asymmetry is skewed to the downside from current levels. We recommend waiting for a pullback toward the €35-€40 range before adopting a constructive stance. Investors seeking AI optical exposure may find better risk/reward in silicon photonics alternatives.

Appendix: MS Estimate Changes (Pre- vs. Post-1Q26)

Changes are minor; gross margin improvement from better opto mix is the key adjustment. The pre-announcement captured most of the opto inflection.